Capital Performance Advisors »

Lyell Immunopharma shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $235 171 1.38

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
OrbiMed Advisors
Alphabet
Geode Capital Management
State Street Corporation
Sc China Holding
MIC Capital Management UK
Opaleye Management

View all funds holding Lyell Immunopharma